课题基金 / 基金详情

项目摘要

项目成果

Jeffrey Nicholas Johnston的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The overarching goal of this proposal is the development of new methods to generate enantioenriched organic compounds. These products are valuable precursors to more elaborate small molecules that are medicinal agents and/or more complex biologically active natural products. The proposed methods specifically target the concise synthesis of 1-amino acids, 1,2-diamino acids, 1-aminophosphonic acids and chiral secondary amines. These methods are based on the development of chiral proton catalysts as new chiral, non-racemic reagents for enantioselective synthesis. The complexes are readily prepared organocatalysts, and are often bench stable solids. They are metal free, and therefore may be referred to as organic catalysts. These studies have the potential to impact the synthesis of both small molecule and "biologic" therapeutic agents. Moreover, the methods enable the metal-free production of functionally dense, single enantiomer (and diastereomer) organic compounds. PUBLIC HEALTH RELEVANCE: This proposal describes the development of chiral small molecule organocatalysts and the corresponding enantioselective reactions. In a single step, chiral nonracemic secondary amines and their derivatives (1-amino acids, 1-aminophosphonates, 1,2- diamino acids) are produced in stereochemically enriched form. These chemical commodities are common subunits of biologically active natural products, biologics, and small molecule therapeutics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of a Mirror-Image Natural Product as an Antiarrhythmic Therapeutic
  • 批准号:
    10589858
  • 项目类别:
  • 资助金额:
    $76.88万
  • 财政年份:
    2020
  • 负责人:
    Jeffrey Nicholas Johnston
  • 依托单位:
Development of a Mirror-Image Natural Product as an Antiarrhythmic Therapeutic
  • 批准号:
    10372134
  • 项目类别:
  • 资助金额:
    $77.71万
  • 财政年份:
    2020
  • 负责人:
    Jeffrey Nicholas Johnston
  • 依托单位:
Development of a Mirror-Image Natural Product as an Antiarrhythmic Therapeutic
  • 批准号:
    9917405
  • 项目类别:
  • 资助金额:
    $78.75万
  • 财政年份:
    2020
  • 负责人:
    Jeffrey Nicholas Johnston
  • 依托单位:
Enantioselective Functionalizations of Azomethines and Alkenes
  • 批准号:
    9050686
  • 项目类别:
  • 资助金额:
    $28.49万
  • 财政年份:
    2009
  • 负责人:
    Jeffrey Nicholas Johnston
  • 依托单位:
海外基金